• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂联素解释了肝癌发病率的性别差异。

Adiponectin accounts for gender differences in hepatocellular carcinoma incidence.

机构信息

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Centro Nacional de Biotecnología, Madrid, Spain.

出版信息

J Exp Med. 2019 May 6;216(5):1108-1119. doi: 10.1084/jem.20181288. Epub 2019 Apr 3.

DOI:10.1084/jem.20181288
PMID:30944152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6504215/
Abstract

Hepatocellular carcinoma (HCC) is the sixth most common cancer type and the fourth leading cause of cancer-related death. This cancer appears with higher incidence in men and during obesity; however, the specific mechanisms underlying this correlation are unknown. Adipose tissue, a key organ in metabolic syndrome, shows evident gender disparities in the production of adipokines. Levels of the important adipokine adiponectin decrease in men during puberty, as well as in the obese state. Here, we show that this decrease in adiponectin levels is responsible for the increased liver cancer risk in males. We found that testosterone activates the protein JNK in mouse and human adipocytes. JNK-mediated inhibition of adiponectin secretion increases liver cancer cell proliferation, since adiponectin protects against liver cancer development through the activation of AMP-activated protein kinase (AMPK) and p38α. This study provides insight into adipose tissue to liver crosstalk and its gender relation during cancer development, having the potential to guide strategies for new cancer therapeutics.

摘要

肝细胞癌(HCC)是第六大常见癌症类型,也是癌症相关死亡的第四大主要原因。这种癌症在男性和肥胖人群中发病率更高;然而,这种相关性的具体机制尚不清楚。脂肪组织是代谢综合征的一个关键器官,在产生脂肪因子方面表现出明显的性别差异。青春期和肥胖状态下,男性的重要脂肪因子脂联素水平下降。在这里,我们表明,这种脂联素水平的下降是导致男性肝癌风险增加的原因。我们发现,睾丸激素激活了小鼠和人类脂肪细胞中的蛋白 JNK。JNK 介导的脂联素分泌抑制增加了肝癌细胞的增殖,因为脂联素通过激活 AMP 激活的蛋白激酶(AMPK)和 p38α 来保护肝脏免受癌症的发展。这项研究深入了解了脂肪组织与肝脏的相互作用及其在癌症发展过程中的性别关系,有可能为新的癌症治疗策略提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/fb3692691a34/JEM_20181288_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/6ddb68659f28/JEM_20181288_GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/3ebfac4d52fa/JEM_20181288_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/817795fa47ec/JEM_20181288_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/ba366260df39/JEM_20181288_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/812dad0112e2/JEM_20181288_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/fb3692691a34/JEM_20181288_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/6ddb68659f28/JEM_20181288_GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/3ebfac4d52fa/JEM_20181288_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/817795fa47ec/JEM_20181288_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/ba366260df39/JEM_20181288_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/812dad0112e2/JEM_20181288_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ebc/6504215/fb3692691a34/JEM_20181288_Fig5.jpg

相似文献

1
Adiponectin accounts for gender differences in hepatocellular carcinoma incidence.脂联素解释了肝癌发病率的性别差异。
J Exp Med. 2019 May 6;216(5):1108-1119. doi: 10.1084/jem.20181288. Epub 2019 Apr 3.
2
Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients.血清脂联素水平与慢性丙型肝炎患者肝癌发展风险的关系。
Int J Cancer. 2011 Nov 1;129(9):2226-35. doi: 10.1002/ijc.25861. Epub 2011 Mar 29.
3
Molecular mechanisms underlying the anti-obesity potential of prunetin, an O-methylated isoflavone.棓丙酯素作为一种 O-甲基化异黄酮,其抗肥胖作用的分子机制。
Biochem Pharmacol. 2013 May 15;85(10):1525-33. doi: 10.1016/j.bcp.2013.02.020. Epub 2013 Feb 21.
4
Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice.西格列汀通过调节脂肪组织炎症和肝脂联素/AMPK 水平改善饮食诱导的代谢综合征和脂肪肝在小鼠。
Biochimie. 2020 Jan;168:198-209. doi: 10.1016/j.biochi.2019.11.005. Epub 2019 Nov 9.
5
Obesity, adipokines and hepatocellular carcinoma.肥胖、脂肪细胞因子与肝细胞癌。
Int J Cancer. 2013 Oct 15;133(8):1776-83. doi: 10.1002/ijc.28105. Epub 2013 Mar 7.
6
Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.慢性乙型肝炎病毒感染携带者的血浆脂肪因子与肝细胞癌风险:台湾的一项前瞻性研究
Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1659-71. doi: 10.1158/1055-9965.EPI-14-0161. Epub 2014 Jun 3.
7
Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.通窍活血汤通过调节脂联素和纤溶酶原激活物抑制剂-1改善肥胖诱导的炎症和血栓前状态。
J Ethnopharmacol. 2016 Nov 4;192:201-209. doi: 10.1016/j.jep.2016.07.023. Epub 2016 Jul 9.
8
Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitro.白藜芦醇在体内和体外参与脂联素与胎球蛋白-A之间的相互作用。
J Nutr Biochem. 2015 Nov;26(11):1254-60. doi: 10.1016/j.jnutbio.2015.06.001. Epub 2015 Jul 17.
9
T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity.T细胞在肥胖患者的脂肪组织中积聚,并在激活时受到调控,正常T细胞表达和分泌上调。
Circulation. 2007 Feb 27;115(8):1029-38. doi: 10.1161/CIRCULATIONAHA.106.638379. Epub 2007 Feb 12.
10
Cardiomyocyte Antihypertrophic Effect of Adipose Tissue Conditioned Medium from Rats and Its Abrogation by Obesity is Mediated by the Leptin to Adiponectin Ratio.大鼠脂肪组织条件培养基的心肌细胞抗肥厚作用及其因肥胖而消除的现象由瘦素与脂联素的比值介导。
PLoS One. 2016 Jan 5;11(1):e0145992. doi: 10.1371/journal.pone.0145992. eCollection 2016.

引用本文的文献

1
The Link Between Dietary Timing and Exercise Performance Through Adipocyte AMPKα2 Signaling.通过脂肪细胞AMPKα2信号传导探讨饮食时间与运动表现之间的联系。
Int J Mol Sci. 2025 Jun 24;26(13):6061. doi: 10.3390/ijms26136061.
2
Sex and gender disparities in hepatocellular carcinoma: insights into risk, diagnosis, and therapeutic outcomes.肝细胞癌中的性别差异:对风险、诊断和治疗结果的见解。
Clin Transl Oncol. 2025 Jun 17. doi: 10.1007/s12094-025-03965-3.
3
Disparities, trends, and projections of cancer mortality burden related to high body mass index in China from 2005 to 2030.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Gender Differences in Adipocyte Metabolism and Liver Cancer Progression.脂肪细胞代谢与肝癌进展中的性别差异
Front Genet. 2016 Sep 20;7:168. doi: 10.3389/fgene.2016.00168. eCollection 2016.
3
Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
2005年至2030年中国与高体重指数相关的癌症死亡负担的差异、趋势及预测
Cell Rep Med. 2025 Jun 17;6(6):102137. doi: 10.1016/j.xcrm.2025.102137. Epub 2025 May 15.
4
Clinical observation of nivolumab combined with cabozantinib in the treatment of advanced hepatocellular carcinoma.纳武单抗联合卡博替尼治疗晚期肝细胞癌的临床观察
World J Gastrointest Oncol. 2025 Apr 15;17(4):103631. doi: 10.4251/wjgo.v17.i4.103631.
5
Serum-biomarker-based population screening model for hepatocellular carcinoma.基于血清生物标志物的肝细胞癌人群筛查模型
iScience. 2025 Feb 8;28(3):111981. doi: 10.1016/j.isci.2025.111981. eCollection 2025 Mar 21.
6
Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development.乙型肝炎患者碱性磷酸酶与前白蛋白比值与肝细胞癌发生的相关性趋势
World J Gastroenterol. 2025 Jan 14;31(2):99349. doi: 10.3748/wjg.v31.i2.99349.
7
Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis.MCJ/DnaJC15缺失促进棕色脂肪组织产热。
Nat Commun. 2025 Jan 13;16(1):229. doi: 10.1038/s41467-024-54353-4.
8
A diet-wide association study for liver cancer risk: findings from a prospective cohort study in Chinese women.一项针对肝癌风险的全膳食关联研究:来自中国女性前瞻性队列研究的结果。
J Nutr Sci. 2024 Dec 17;13:e95. doi: 10.1017/jns.2024.86. eCollection 2024.
9
Adipokines: masterminds of metabolic inflammation.脂肪因子:代谢性炎症的幕后主使
Nat Rev Immunol. 2025 Apr;25(4):250-265. doi: 10.1038/s41577-024-01103-8. Epub 2024 Nov 7.
10
Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma.东亚肝细胞癌基因组谱中的性别差异研究。
Discov Oncol. 2024 Jul 9;15(1):276. doi: 10.1007/s12672-024-01131-9.
二甲双胍的使用可提高糖尿病肝癌患者的生存率:系统评价与荟萃分析。
Oncotarget. 2016 Oct 4;7(40):66202-66211. doi: 10.18632/oncotarget.11033.
4
Adiponectin, the past two decades.脂联素,过去二十年。 (这段原文似乎不太完整,翻译出来的内容可能不太符合完整语境的准确意思)
J Mol Cell Biol. 2016 Apr;8(2):93-100. doi: 10.1093/jmcb/mjw011. Epub 2016 Mar 18.
5
Functional and genetic deconstruction of the cellular origin in liver cancer.肝癌中细胞起源的功能和遗传解构。
Nat Rev Cancer. 2015 Nov;15(11):653-67. doi: 10.1038/nrc4017.
6
Stress kinases in the modulation of metabolism and energy balance.应激激酶对代谢和能量平衡的调节作用
J Mol Endocrinol. 2015 Oct;55(2):R11-22. doi: 10.1530/JME-15-0146.
7
Sex differences in adipose tissue: It is not only a question of quantity and distribution.脂肪组织中的性别差异:这不仅仅是数量和分布的问题。
Adipocyte. 2013 Jul 1;2(3):128-34. doi: 10.4161/adip.24075. Epub 2013 Aug 1.
8
Mouse models for liver cancer.肝癌的小鼠模型。
Mol Oncol. 2013 Apr;7(2):206-23. doi: 10.1016/j.molonc.2013.01.005. Epub 2013 Feb 5.
9
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.二甲双胍以剂量依赖的方式降低肝细胞癌风险:基于人群和体外研究。
Gut. 2013 Apr;62(4):606-15. doi: 10.1136/gutjnl-2011-301708. Epub 2012 Jul 7.
10
The role of adiponectin in cancer: a review of current evidence.脂联素在癌症中的作用:当前证据综述。
Endocr Rev. 2012 Aug;33(4):547-94. doi: 10.1210/er.2011-1015. Epub 2012 Apr 30.